OIS at AAO 2015

Mati Therapeutics

Nov 12, 2015 8:54am ‐ Nov 12, 2015 9:02am


Mati Therapeutics Inc. is developing an enhanced drug delivery platform to administer therapeutics to the eye. Due to Mati’s ability to adjust this platform, this technology can be used to treat a range of ophthalmic conditions with multiple therapies in late stage development.


You must be logged in and own this session in order to post comments.